Tag: pharmaceuticals
-
Trial Demonstrates 3-D Printed Ear Tissue Implant
A patient in a clinical trial received an implant made of three-dimensional printed tissue to replace a deformed ear caused by microtia, a congenital condition.
-
GSK Acquires Advanced Vaccine Biotech in $3.3B Deal
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses.
-
Grant Funds Epilepsy Stem Cell Therapy Trial
A developer of stem cell therapies for neurological disorders is receiving an $8 million grant to advance a treatment for a common type of epilepsy.
-
AI Drug Company Creating Covid-19 Therapy for Rapid Delivery
A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced.
-
Trial Shows Therapy Controls Gut Disorder with Healthy Microbes
Results from a clinical trial show a microbiome treatment produces healthy gut microbes that reduce recurrences of C. difficile infections.
-
Addiction Therapy, VR Companies Partner on Veteran PTSD
A developer of addiction therapies and virtual reality software company are collaborating on help for veterans suffering from post-traumatic stress disorder.
-
Venture Investor Funds Cell Therapy Targeting Tech
A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases.
-
Precision Antibacterial Company Raises $35M in New Funds
A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds.
-
Trial Shows Gene Therapy Results with Sickle Cell Disease
Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years.
-
Early Trial Data Show Crispr Cancer Therapy Response
Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a clinical response, but with some adverse effects.